Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
genetic diseases
Pharma
FDA approves Soleno's Vykat XR for insatiable hunger disorder
The FDA has approved Soleno Therapeutics' Vykat XR as the first treatment for insatiable hunger related to the rare condition Prader-Willi Syndrome.
Kevin Dunleavy
Mar 27, 2025 11:24am
Tryngolza's FDA approval marks 'pivotal moment' for Ionis: CEO
Dec 20, 2024 8:32am
Alnylam embarks on campaign to drive hATTR amyloidosis diagnoses
Mar 13, 2024 10:30am
Pharming scores FDA nod for rare disease drug Joenja
Mar 27, 2023 11:06am
